BCMU
MDT icon

BlueCrest Capital Management (UK)’s Medtronic MDT Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$638K – 612
2014
Q2 		$638K Buy
+10,000
New +$607K 0.02% 422

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlueCrest Capital Management (UK)'s MDT Position: Q3 2014 in Review

BlueCrest Capital Management (UK) opened a new position in Medtronic (MDT) in Q3 2014: 4,035 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #464 among its holdings. This is a return to the name: BlueCrest Capital Management (UK) previously reported a position in MDT as recently as Q1 2014.

BlueCrest Capital Management (UK) first reported a position in MDT in Q4 2013 and has held it in 3 quarters since. The position peaked at $10.7M in Q4 2013. 1,135 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

  • BlueCrest Capital Management (UK) held 4,035 shares of Medtronic worth $250K as of Q3 2014.
  • Medtronic was a new BlueCrest Capital Management (UK) position in Q3 2014.
  • Medtronic made up 0.01% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #464 holding.
  • BlueCrest Capital Management (UK) first reported a position in Medtronic in Q4 2013 and has held it in 3 quarters since.
  • BlueCrest Capital Management (UK)'s Medtronic position peaked at $10.7M in Q4 2013.
  • 1,135 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.